Market Problem
70%+
Indians are protein deficient
Growth Driver
Urbanization
Rapidly increasing health consciousness
Core Opportunity
Youth & Profs
High spending power for health tech
Demographic Shift
Shift from carbohydrate-heavy to protein-rich diets among millennials.
Untapped Segments
Women's health and elder care are largely ignored by current players.
Trust Gap
Local brands suffer from certification and quality transparency issues.
Convenience
Ready-to-drink (RTD) format preferred over messy powders.
Consumer Insights Summary
Segmentation & STP Dashboard
| Segment | Age | Income | Key Motivation | Price Sensitivity | Target Priority | Attractiveness |
|---|---|---|---|---|---|---|
| Urban Professionals | 25–40 | High | "Efficiency/Health" | Low | Primary | High |
| Fitness Youth | 18–28 | Mid | "Performance/Gains" | Medium | Secondary | High |
| Health-Conscious Women | 22–45 | Mid-High | "Well-being/Weight" | Medium | Secondary | Medium |
| Price-Sensitive Students | 16–22 | Low | "Daily Protein" | High | Opportunistic | Low |
Positioning Map
Pricing Strategy
| Tier | Price Range | Target Segment | Value Proposition |
|---|---|---|---|
| Value | ₹45–60 | Students / First-time users | Basic Nutrition |
| Standard | ₹75–95 | Office Professionals | Daily Maintenance |
| Premium | ₹100–150 | Fitness Enthusiasts / Pros | Peak Performance |
*Designed to drive market penetration at entry and maximize margins at the top end.
4Ps Strategy Alignment Grid
| P-Factor | GTM Strategy | Consumer Insight Addressed | |
|---|---|---|---|
| Product | 20g protein, low sugar, FSSAI certified | Safety & Quality concerns | |
| Price | Tiered architecture (Value → Premium) | Extreme price sensitivity | |
| Place | Modern trade, Gym kiosks, Quick-commerce | Immediate accessibility need | |
| Promotion | Expert influencers + QR code transparency | Major trust deficit in local players |
G-STIC Strategic Control Panel
Core Goals
Strategy
Key Tactics
Metro Launch + Influencers + Tiered pricing
Sales Volume
120k+
+12% vs FC
Brand Trust
4.8/5
Top Quartile
Trial Rate
18.5%
Target: 15%
Repeat Rate
42%
Benchmark: 35%